AU7361900A - Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins - Google Patents

Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins

Info

Publication number
AU7361900A
AU7361900A AU73619/00A AU7361900A AU7361900A AU 7361900 A AU7361900 A AU 7361900A AU 73619/00 A AU73619/00 A AU 73619/00A AU 7361900 A AU7361900 A AU 7361900A AU 7361900 A AU7361900 A AU 7361900A
Authority
AU
Australia
Prior art keywords
prevention
compositions
treatment
methods
heat shock
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73619/00A
Other languages
English (en)
Inventor
Rajiv Y. Chandawarkar
Pramod K Srivastava
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fordham University
Original Assignee
Fordham University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fordham University filed Critical Fordham University
Publication of AU7361900A publication Critical patent/AU7361900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6043—Heat shock proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU73619/00A 1999-09-10 2000-09-08 Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins Abandoned AU7361900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39365299A 1999-09-10 1999-09-10
US09393652 1999-09-10
PCT/US2000/024711 WO2001017554A1 (fr) 1999-09-10 2000-09-08 Procedes et compositions pour le traitement et la prevention des rejets de greffes utilisant des proteines de choc thermique

Publications (1)

Publication Number Publication Date
AU7361900A true AU7361900A (en) 2001-04-10

Family

ID=23555669

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73619/00A Abandoned AU7361900A (en) 1999-09-10 2000-09-08 Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins

Country Status (4)

Country Link
EP (1) EP1218030A4 (fr)
AU (1) AU7361900A (fr)
CA (1) CA2383213A1 (fr)
WO (1) WO2001017554A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2378097A1 (fr) 1999-07-08 2001-01-18 Stressgen Biotechnologies Corporation Stimulation d'une reponse de type th-1 in vitro
EP1296711B1 (fr) 2000-06-26 2006-05-17 Stressgen Biotechnologies Corporation Hpv-e7 pour le traitement des infections par le papillomavirus
US6921534B2 (en) 2001-02-05 2005-07-26 Stressgen Biotechnologies Corporation Hepatitis B virus treatment
ES2433915T3 (es) 2002-05-21 2013-12-13 Irun R. Cohen Vacunas de ADN que codifican proteínas de choque térmico
AU2002952492A0 (en) * 2002-11-06 2002-11-21 Cbio Limited Chaperonin 10 immunosuppression
JP2007530420A (ja) * 2003-07-07 2007-11-01 ザ・ジェネラル・ホスピタル・コーポレイション ｆｕｇｅｔａｃｔｉｃタンパク質、組成物および使用方法
BRPI0708865A8 (pt) 2006-03-14 2019-01-22 Univ Oregon Health & Science métodos para produzir uma resposta imune à tuberculose
US8188214B2 (en) 2007-02-28 2012-05-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Brachyury polypeptides and methods for use
EP3578195B1 (fr) 2008-06-26 2023-08-09 Zevra Denmark A/S Utilisation du hsp70 en tant que régulateur de l'activité enzymatique
US8664183B2 (en) 2009-02-27 2014-03-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services SPANX-B polypeptides and their use
CN102462841A (zh) * 2010-11-09 2012-05-23 中国科学院微生物研究所 一种促进gp96蛋白的免疫活性的方法及其应用
RU2013125923A (ru) 2010-11-30 2015-01-10 Орфазиме Апс СПОСОБЫ УВЕЛИЧЕНИЯ ВНУТРИКЛЕТОЧНОЙ АКТИВНОСТИ Hsp70
EP2895191B1 (fr) 2012-09-14 2019-06-05 The U.S.A. as represented by the Secretary, Department of Health and Human Services Protéine brachyury, vecteurs adénoviraux codant pour la protéine brachyury, et leur utilisation
BR102014002362A8 (pt) 2014-01-30 2018-04-17 Uniao Brasileira De Educacao E Assistencia Mantenedora Da Puc Rs método de imunomodulação e/ou preservação de órgãos ex-vivo, composições, processo e usos
HUE054957T2 (hu) 2014-09-15 2021-10-28 Orphazyme As Arimoklomol készítése
WO2017024000A1 (fr) 2015-08-03 2017-02-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mutants de délétion de la protéine brachyury, vecteurs sans levure codant pour les mutants de délétion de la protéine brachyury, et leur utilisation
WO2017178029A1 (fr) 2016-04-13 2017-10-19 Orphazyme Aps Protéines de choc thermique et homéostasie du cholestérol
HUE052158T2 (hu) 2016-04-29 2021-04-28 Orphazyme As Arimoklomol a glükocerebroszidázzal társult rendellenességek kezeléséhez
IL303026A (en) 2020-11-19 2023-07-01 Zevra Denmark As Processes for preparing arimoclomol citrate and its intermediates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891653A (en) * 1995-12-29 1999-04-06 Attfield; Derrick Cecil Method of suppressing graft rejection by means of stress proteins

Also Published As

Publication number Publication date
WO2001017554A9 (fr) 2002-09-26
EP1218030A4 (fr) 2004-09-15
EP1218030A1 (fr) 2002-07-03
WO2001017554A1 (fr) 2001-03-15
CA2383213A1 (fr) 2001-03-15

Similar Documents

Publication Publication Date Title
AU7361900A (en) Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
NZ514350A (en) Compositions and methods for effecting the levels of cholesterol
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2002320456A1 (en) Removable stent and method of using the same
ZA989461B (en) Methods and compositions for the treatment of autoimmune disease using heat shock proteins
AU2212299A (en) Compositions and methods for the treatment of tumor
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU9016898A (en) Methods and compositions for treatment of restenosis
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU1590201A (en) Compositions and methods for treating autoimmune diseases and transplant rejections
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU2002346882A1 (en) Methods for the treatment of osteoarthritis and compositions thereof
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
IL130968A0 (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6210600A (en) Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase